Abstract
Background: Organ dysfunctions and medical complications, such as renal failure, liver impairment, coagulation disorders, cardiovascular and respiratory illnesses, may hamper an adequate pain management in haematological patients.
Aim: To summarize current knowledge on pain management in hematological patients presenting major organ dysfunctions and comorbidity. We also attempted to provide recommendations to optimize analgesia and to minimize side effects in the setting of medically compromised and frail haematological patients.
Methods: A systematic search of the literature, using relevant key words, was conducted in PubMed.
Results and conclusions: Pain in hematological patients is a common symptom and is often multi-factorial. Most pharmacotherapeutic measures, including causal therapies, analgesics and adjuvant agents routinely applied in pain management, may also be used in the setting of clinical frailty and medical comorbidities; however, comprehensive clinical and functional patient’s evaluations and a careful consideration of expected benefits and potential adverse events are required.
Keywords: Analgesics, anticoagulant oral therapy, blood diseases, cardiovascular diseases, chronic illnesses, coagulation defects, haematology, heparin, liver dysfunctions, liver cirrhosis, liver failure, medical complications, non steroidal antiinflammatory drugs (NSAIDs), opioids, oral anticoagulant therapy, pain, pain management, paracetamol, renal impairment, thrombocytopenia
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Volume: 10 Issue: 2
Author(s): Pasquale Niscola, Andrea Tendas, Marco Giovannini, Laura Scaramucci, Luca Cupelli, Michele Ferrannini, Gregorio Antonio Brunetti, Francesco Bondanini, Roberto Palumbo, Alessio Perrotti, Claudio Romani, Claudio Cartoni, Fabio Efficace and Paolo de Fabritiis
Affiliation:
Keywords: Analgesics, anticoagulant oral therapy, blood diseases, cardiovascular diseases, chronic illnesses, coagulation defects, haematology, heparin, liver dysfunctions, liver cirrhosis, liver failure, medical complications, non steroidal antiinflammatory drugs (NSAIDs), opioids, oral anticoagulant therapy, pain, pain management, paracetamol, renal impairment, thrombocytopenia
Abstract: Background: Organ dysfunctions and medical complications, such as renal failure, liver impairment, coagulation disorders, cardiovascular and respiratory illnesses, may hamper an adequate pain management in haematological patients.
Aim: To summarize current knowledge on pain management in hematological patients presenting major organ dysfunctions and comorbidity. We also attempted to provide recommendations to optimize analgesia and to minimize side effects in the setting of medically compromised and frail haematological patients.
Methods: A systematic search of the literature, using relevant key words, was conducted in PubMed.
Results and conclusions: Pain in hematological patients is a common symptom and is often multi-factorial. Most pharmacotherapeutic measures, including causal therapies, analgesics and adjuvant agents routinely applied in pain management, may also be used in the setting of clinical frailty and medical comorbidities; however, comprehensive clinical and functional patient’s evaluations and a careful consideration of expected benefits and potential adverse events are required.
Export Options
About this article
Cite this article as:
Niscola Pasquale, Tendas Andrea, Giovannini Marco, Scaramucci Laura, Cupelli Luca, Ferrannini Michele, Antonio Brunetti Gregorio, Bondanini Francesco, Palumbo Roberto, Perrotti Alessio, Romani Claudio, Cartoni Claudio, Efficace Fabio and de Fabritiis Paolo, Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses, Cardiovascular & Hematological Agents in Medicinal Chemistry 2012; 10 (2) . https://dx.doi.org/10.2174/187152512800388902
DOI https://dx.doi.org/10.2174/187152512800388902 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Anti-inflammatory Therapies for Atherosclerosis
Current Pharmaceutical Design Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Current Neuropharmacology Synthesis and Antimicrobial Activity of Nitroalkenyl Arenes
Anti-Infective Agents Review of Trans-Atlantic Cardiovascular Best Medical Therapy Guidelines – Recommendations for Asymptomatic Carotid Atherosclerosis
Current Vascular Pharmacology A Box-Behnken Optimized Methodology for the Quantification of Diclofenac using a Carbon Paste-Multiwalled Carbon Nanotubes Electrode
Current Analytical Chemistry ADP Receptors-Targets for Developing Antithrombotic Agents
Current Pharmaceutical Design Anti Inflammatory and Anti Arthritic Activity of Different Milk Based Formulation of Curcumin in Rat Model
Current Drug Delivery Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors
Recent Patents on Anti-Cancer Drug Discovery Gabapentin Antioxidant Derivatives with Anti-Inflammatory and Neuroprotective Potency
Letters in Drug Design & Discovery Status of Dyslipidemia in Vitamin D Supplemented Argentinean Indigenous Children Versus A Non-supplemented Mixed Population Group
Cardiovascular & Hematological Agents in Medicinal Chemistry Effect of Fenofibrate on the Concentration and Relative Distribution of LDL Subfractions in Patients with Combined Dyslipidemia
Letters in Drug Design & Discovery Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)
Current Reviews in Clinical and Experimental Pharmacology p53 Peptide Prevents LITAF-Induced TNF-Alpha-Mediated Mouse Lung Lesions and Endotoxic Shock
Current Molecular Medicine The Potential Roles of Gamma-Glutamyltransferase Activity in the Progression of Atherosclerosis and Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) The Central Sympathetic Nervous System: A New Target for Cardioprotective Drugs
Drug Design Reviews - Online (Discontinued) Chymase Inhibitor As a Novel Therapeutic Strategy for Anti-Vascular Remodeling
Vascular Disease Prevention (Discontinued) Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?
Current Medicinal Chemistry Anti Citrullinated Protein Antibodies and Mechanism of Action of Common Disease Modifying Drugs - Insights in Pathomechanisms of Autoimmunity
Current Pharmaceutical Design Alpha-1 Antitrypsin Deficiency: Treatment Beyond Augmentation Therapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Protective Role of Italian Juglans regia L. nut Ethanolic Extract in Human Keratinocytes under Oxidative and Inflammatory Stress
Current Pharmaceutical Biotechnology